for Journals by Title or ISSN
for Articles by Keywords
help
Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Journals are published.
Already have an account? Sign In to see the journals you follow.
Journal Cover Consumer Drugs
  [0 followers]  Follow
    
   Full-text available via subscription Subscription journal
   ISSN (Print) 1530-1206
   Published by Informa plc Homepage  [9 journals]
  • Consumer Health Weekly Trademark Review Sept. 12, 2017
    • Abstract: Compiled from the Official Gazette of the US Patent and Trademark Office, Class 3 (Cosmetics and Cleaning Preps) and Class...      Related Stories
      Australia Sees Decline In Generic Filings, Rise in Extensions And ADR Reports
      Sanofi Secures EMA Accelerated Assessment For Sleeping Sickness Drug
      EMA Concludes Recombinant Factor VIII Medicines Pose No Greater Risk Of Inhibition 
      PubDate: Mon, 18 Sep 2017 13:06:23 GMT
       
  • Perrigo Glows From Mucinex Private Label Plan, Starboard Plug
    • Abstract: Perrigo plans to introduce two more Mucinex store brand products within six months after a series of manufacturing stumbles, CEO...      Related Stories
      Consumer Health Weekly Trademark Review Sept. 12, 2017
      Australia Sees Decline In Generic Filings, Rise in Extensions And ADR Reports
      Sanofi Secures EMA Accelerated Assessment For Sleeping Sickness Drug 
      PubDate: Fri, 15 Sep 2017 18:10:15 GMT
       
  • Consumer Health Weekly Trademark Review Sept. 5, 2017
    • Abstract: Compiled from the Official Gazette of the US Patent and Trademark Office, Class 3 (Cosmetics and Cleaning Preps) and Class...      Related Stories
      Final ICH Addendum Offers Latest Perspectives On Pediatric Drug Development
      US FDA May Change Opioid Labeling To Limit Dispensing By Indication
      Making Imodium Rx-Only No Help On Curbing Opioid Abuse – CHPA 
      PubDate: Fri, 15 Sep 2017 00:01:07 GMT
       
  • 'Not As Easy' OTC Codeine Label Changes Worry FDA Rx
           Product Advisors
    • Abstract: FDA officials acknowledge at the Pediatric Advisory Committee Sept. 11 that labeling restrictions for opioid-containing Rx antitussives for pediatric cough...      Related Stories
      ICH Expansion Prompts WHO To Review Definition Of ?Stringent Regulatory Authorities?
      ‘Surprised and Disappointed’ Santhera To Fight EU’s DMD Rejection
      Recent And Upcoming FDA Advisory Committee Meetings 
      PubDate: Thu, 14 Sep 2017 19:00:00 GMT
       
  • Making Imodium Rx-Only No Help On Curbing Opioid Abuse – CHPA
    • Abstract: Making OTC diarrhea remedy loperamide Rx-only is unlikely to reduce abuse and would cause problems for millions of US consumers...      Related Stories
      ?Not As Easy? OTC Codeine Label Changes Worry FDA Rx Product Advisors
      Making Imodium Rx-Only No Help On Curbing Opioid Abuse – CHPA 
      PubDate: Thu, 14 Sep 2017 19:00:00 GMT
       
  • Exclusivity Provision Seems Likely To Surface In OTC Monograph Bill
    • Abstract: The House Health subcommittee asks about allowing manufacturers? periods of US market exclusivity for some approved OTC monograph proposals, among...      Related Stories
      ICH Expansion Prompts WHO To Review Definition Of ?Stringent Regulatory Authorities?
      ‘Surprised and Disappointed’ Santhera To Fight EU’s DMD Rejection
      Recent And Upcoming FDA Advisory Committee Meetings 
      PubDate: Thu, 14 Sep 2017 00:03:51 GMT
       
  • Legislators On OTC Monograph Reform: What Took You So Long'
    • Abstract: "If the system is broken … my gosh, does it take 45 years for the FDA to say, ?we need...      Related Stories
      Final ICH Addendum Offers Latest Perspectives On Pediatric Drug Development
      Jazz On Track With Q4 EU Filing for Leukemia Treatment Vyxeos
      Exclusivity Provision Seems Likely To Surface In OTC Monograph Bill 
      PubDate: Thu, 14 Sep 2017 00:03:46 GMT
       
  • Colgate Boosts Digital Marketing 20% To Engage With Consumers
    • Abstract: Colgate targets at least 20% of its global media spending digitally as part of a larger marketing push to help...      Related Stories
      Sanofi Is Aiming For European Accelerated Assessment For Sleeping Sickness Drug
      New Treatments For Psoriasis, Ovarian Cancer And MS Seeking CHMP Thumbs Up This Week 
      PubDate: Tue, 12 Sep 2017 17:00:39 GMT
       
  • Legacy Consumer Health Firms Invest To Compete In Start-Ups'
           Realm: E-Commerce
    • Abstract: J&J, Colgate, P&G and Church & Dwight look to e-commerce to regain market share from smaller, nimble consumer health brands...      Related Stories
      Sanofi Is Aiming For European Accelerated Assessment For Sleeping Sickness Drug
      New Treatments For Psoriasis, Ovarian Cancer And MS Seeking CHMP Thumbs Up This Week 
      PubDate: Tue, 12 Sep 2017 16:42:11 GMT
       
  • Second Wind For OTC Monograph User Fees Legislation In House Hearing
    • Abstract: US House health subcommittee?s “Modernizing FDA’s Regulation of Over-the-Counter Drugs” hearing Sept. 13 will "examine draft legislation to establish" a...      Related Stories
      ICH Consults On Harmonized Standards For Choosing Estimands In Clinical Trials
      Celltrion Biosimilar Is Latest To Run Into GMP Compliance Concerns 
      PubDate: Fri, 08 Sep 2017 18:05:26 GMT
       
  • Amarin's Omega-3 Fair Trade Complaint Questions US Dietary
           Ingredient Standards
    • Abstract: Amarin?s recent fair trade complaint targetting purified EPA dietary supplements and formulations also raises broader questions about using synthetic dietary...      Related Stories
      Second Wind For OTC Monograph User Fees Legislation In House Hearing
      WHO Guidance On How To Test ‘Suspect’ Falsified Medicines Draws Nearer
      ICH Demystifies Q11 Guide On Selection Of Starting Materials 
      PubDate: Thu, 07 Sep 2017 15:12:33 GMT
       
  • Consumer Health Weekly Trademark Review Aug. 29, 2017
    • Abstract: Compiled from the Official Gazette of the US Patent and Trademark Office, Class 3 (Cosmetics and Cleaning Preps) and Class...      Related Stories
      Overdose Concerns Prompt EMA To Call For Suspension Of Modified-Release Paracetamol Medicines
      Insmed Phase III Date Support Accelerated Approval For ALIS In Rare Lung Disease
      FDA Wins Abilify Exclusivity Battle; Court Rejects Otsuka?s ?Legal Equivalence? 
      PubDate: Wed, 06 Sep 2017 09:03:17 GMT
       
  • Warnings, Recalls: Consumer Health Regulatory News
    • Abstract: Rodent feces in Chinese OTC firm’s facility; and Major, Rugby recall Pharmatech-made OTCs.      Related Stories
      Keeping Track: US FDA?s Late Summer Approval Extravaganza Stars Three Novel Agents, Features Return Of Mylotarg
      Shanghai’s Tough Proposals For Medical Sales Reps Draw Ire
      In Case You Missed It … News On Biosimilars, GMPs, Real-World Evidence 
      PubDate: Tue, 05 Sep 2017 00:05:09 GMT
       
  • Amarin Seeks ITC Action Against Products 'Cloaked' As
           Dietary Supplements
    • Abstract: Seeking to protect its competitive interests, Vascepa marketer asks the US International Trade Commission to investigate importation and sale of...      Related Stories
      New BeNeLuxA Access To Meds Initiative Pilots Are Under Way
      Two Regulators-Only Groups Agree To Maximize Synergies Under Single Entity
      FDA?s NDA And BLA Approvals: Kymriah, Vabomere, Cyltezo 
      PubDate: Wed, 30 Aug 2017 16:19:17 GMT
       
  • Switches, Pediatric Products Highlight OTC Outlook In Independent
           Pharmacies
    • Abstract: OTC cold and allergy product sales lead the health, wellness and beauty segment in 16,000 US independent pharmacies, says Hamacher...      Related Stories
      New BeNeLuxA Access To Meds Initiative Pilots Are Under Way
      Two Regulators-Only Groups Agree To Maximize Synergies Under Single Entity
      FDA?s NDA And BLA Approvals: Kymriah, Vabomere, Cyltezo 
      PubDate: Wed, 30 Aug 2017 11:43:43 GMT
       
  • Consumer Health Weekly Trademark Review Aug. 15, 2017
    • Abstract: Compiled from the Official Gazette of the US Patent and Trademark Office, Class 3 (Cosmetics and Cleaning Preps) and Class...      Related Stories
      NZ Agency Latest To Warn Of Hepatitis C Drug Interaction With Warfarin
      UK Reveals Industrial Strategy For Boosting Life Science Sector
      FDA Drafts Guidance To Dispel Confusion About DSCSA Trading Partners 
      PubDate: Tue, 29 Aug 2017 12:04:47 GMT
       
  • OTC, Supplement Co-Packaging Potential Could Be Clipped By FDA Proposed
           Rule
    • Abstract: Innovus Pharmaceuticals is among the firms offering supplements and OTC drugs sold together, an option CRN trade group encourages FDA...      Related Stories
      Parties Vie For Place At EMA’s First Ever Public Hearing On Medicines Safety
      Switches, Pediatric Products Highlight OTC Outlook In Independent Pharmacies
      FDA Drafts Guidance To Dispel Confusion About DSCSA Trading Partners 
      PubDate: Tue, 29 Aug 2017 11:05:04 GMT
       
  • Drug Co-Packaging Proposed Rule Could Hamper Some OTC Marketing
    • Abstract: OTC drug packages with separate containers of a product?s daytime and nighttime formulations could be mislabeled under US FDA’s proposed...      Related Stories
      Parties Vie For Place At EMA’s First Ever Public Hearing On Medicines Safety
      Switches, Pediatric Products Highlight OTC Outlook In Independent Pharmacies
      FDA Drafts Guidance To Dispel Confusion About DSCSA Trading Partners 
      PubDate: Tue, 29 Aug 2017 11:04:58 GMT
       
  • PharmaTech’s Water Problem Reaches OTCs In Ninjacof Recall
    • Abstract: Ninjacof cough and cold products are recalled by Richland, MS-based marketer Centurion Labs as a precaution after FDA warns the...      Related Stories
      Keeping Track: Breakthrough Therapies Becoming Breakthrough Applications For Tezacaftor, Burosumab, Emicizumab
      US Approvals Roundup: Cyltezo Biosimilar, Victoza CV Benefit, Gocovri In PD, Kedrab Rabies Biologic, Gout Combo Duzallo
      Spark Therapeutics? Vision Loss Gene Therapy Gets FDA Panel Review 
      PubDate: Fri, 25 Aug 2017 15:00:13 GMT
       
  • Waiting For Congress: Reforming, Paying For FDA OTC Monograph Program
    • Abstract: FDA officials emphasize that without legislation from Congress, the OTC monograph program is not changing, and without a user fee...      Related Stories
      EMA Looks At New Ways To Define And Prioritize Unmet Pediatric Needs
      EU, US Commit To Sharing Full Inspection Reports To Supplement GMP Mutual Recognition
      Help Needed! BIA Enlists Members To Provide Expert Evidence For UK Government’s Brexit Talks 
      PubDate: Wed, 23 Aug 2017 17:53:38 GMT
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
Home (Search)
Subjects A-Z
Publishers A-Z
Customise
APIs
Your IP address: 54.159.64.172
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2016